Literature DB >> 29962097

Childhood pilomatricomas: Associated anomalies.

Camile Richet1, Aude Maza1, Isabelle Dreyfus1, Emmanuelle Bourrat2, Juliette Mazereeuw-Hautier1.   

Abstract

Pilomatricoma is a common benign tumor in children. We present a review of the literature with the aim of helping clinicians manage these patients. A detailed review of the literature was performed in the PubMed database using an exhaustive list of Medical Subject Heading words. One thousand four hundred fifty-eight children were described in retrospective series and case reports. An associated disease was found in 32 children (2.2%), most of whom had several pilomatricomas (n = 23); 9 had a single lesion. Based on this literature review, we recommend reassuring the family and then conducting a detailed interview regarding past medical and family history and a thorough clinical examination for signs of Turner syndrome, constitutional mismatch repair deficiency, Kabuki syndrome, Steiner's myotonic dystrophy, or Gardner syndrome. Regular long-term clinical follow-up is recommended. Specific paraclinical examinations should be performed only in cases of other clinical anomalies or a positive family history. Pilomatricoma requires management because it may be associated with other potentially serious diseases, especially when multiple lesions are present.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  childhood pilomatricoma; multiple pilomatricoma; pilomatricoma

Mesh:

Year:  2018        PMID: 29962097     DOI: 10.1111/pde.13564

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  A case of multiple perforating pilomatricomas.

Authors:  Mai Endo; Toshiyuki Yamamoto
Journal:  An Bras Dermatol       Date:  2022-02-10       Impact factor: 2.113

Review 2.  Kabuki Syndrome-Clinical Review with Molecular Aspects.

Authors:  Snir Boniel; Krystyna Szymańska; Robert Śmigiel; Krzysztof Szczałuba
Journal:  Genes (Basel)       Date:  2021-03-25       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.